Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review
Current oncology (Toronto, Ont)（2023）
Key words
antibody–drug conjugate (ADCs),breast cancer,HER2-low
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined